|
ATOS Atossa Therapeutics Inc 1488039 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-9,589,000.00 |
| Balance Sheet |
|
Current Assets
|
$36,668,000.00 |
|
Assets
|
$37,943,000.00 |
|
Current Liabilities
|
$7,457,000.00 |
|
Liabilities
|
$7,457,000.00 |
|
Equity
|
$30,486,000.00 |
|
Shares Out
|
8611361.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,581,000.00 |
| Market Analysis |
Market Cap
|
$18,858,880.59 |
|
Price
|
$2.12 |
|
BVPS
|
3.54 |
|
PB
|
0.62 |
|
EPS
|
-1.11 |
|
FCF
|
$-9,581,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATOS documents filed with the SEC.
ATOS Filings
Clear
